Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Ok Lee

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|September 18, 2013
Determination of androgen receptor degradation enhancer ASC-J9(®) in mouse sera and organs with liquid chromatography tandem mass spectrometryShu Fang Soh, Chiung-Kuei Huang, Soo Ok Lee, et al.
Hepatology (Baltimore, Md.)|November 15, 2012
Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosisChiung-Kuei Huang, Soo Ok Lee, Kuo-Pao Lai, et al.
The American Journal of Pathology|December 11, 2012
New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cellsKuo-Pao Lai, Chiung-Kuei Huang, Yu-Jia Chang, et al.
Molecular Oncology|September 3, 2017
Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levelsLiJun Xu, XiaoDong Chen, MingJing Shen, et al.
The Journal of Urology|July 12, 2005
Interleukin-6 polymorphism is associated with more aggressive prostate cancerDongfeng Tan, Xiuxian Wu, Min Hou, et al.
The Journal of Biological Chemistry|May 21, 2013
Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasisTzu-Hua Lin, Soo Ok Lee, Yuanjie Niu, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|September 29, 2018
RETRACTED: Neuroendocrine differentiation contributes to radioresistance development and metastatic potential increase in non-small cell lung cancerRongying Zhu, Xiaodong Yang, Xiang Xue, et al.
Hypertension (Dallas, Tex. : 1979)|September 2, 2015
Androgen receptor promotes abdominal aortic aneurysm development via modulating inflammatory interleukin-1α and transforming growth factor-β1 expressionChiung-Kuei Huang, Jie Luo, Kuo-Pao Lai, et al.
International Journal of Cancer|July 1, 2014
TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signalingXianfan Ding, Dong-Rong Yang, Soo Ok Lee, et al.
Molecular Endocrinology (Baltimore, Md.)|June 24, 2014
Androgen receptor enhances kidney stone-CaOx crystal formation via modulation of oxalate biosynthesis & oxidative stressLiang Liang, Lei Li, Jing Tian, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Journal of Pharmaceutical and Biomedical Analysis|September 18, 2013
Determination of androgen receptor degradation enhancer ASC-J9(®) in mouse sera and organs with liquid chromatography tandem mass spectrometryShu Fang Soh, Chiung-Kuei Huang, Soo Ok Lee, et al.
Hepatology (Baltimore, Md.)|November 15, 2012
Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosisChiung-Kuei Huang, Soo Ok Lee, Kuo-Pao Lai, et al.
The American Journal of Pathology|December 11, 2012
New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cellsKuo-Pao Lai, Chiung-Kuei Huang, Yu-Jia Chang, et al.
Molecular Oncology|September 3, 2017
Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levelsLiJun Xu, XiaoDong Chen, MingJing Shen, et al.
The Journal of Urology|July 12, 2005
Interleukin-6 polymorphism is associated with more aggressive prostate cancerDongfeng Tan, Xiuxian Wu, Min Hou, et al.
The Journal of Biological Chemistry|May 21, 2013
Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasisTzu-Hua Lin, Soo Ok Lee, Yuanjie Niu, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|September 29, 2018
RETRACTED: Neuroendocrine differentiation contributes to radioresistance development and metastatic potential increase in non-small cell lung cancerRongying Zhu, Xiaodong Yang, Xiang Xue, et al.
Hypertension (Dallas, Tex. : 1979)|September 2, 2015
Androgen receptor promotes abdominal aortic aneurysm development via modulating inflammatory interleukin-1α and transforming growth factor-β1 expressionChiung-Kuei Huang, Jie Luo, Kuo-Pao Lai, et al.
International Journal of Cancer|July 1, 2014
TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signalingXianfan Ding, Dong-Rong Yang, Soo Ok Lee, et al.
Molecular Endocrinology (Baltimore, Md.)|June 24, 2014
Androgen receptor enhances kidney stone-CaOx crystal formation via modulation of oxalate biosynthesis & oxidative stressLiang Liang, Lei Li, Jing Tian, et al.
Pageof 9